Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01601431 · ClinicalTrials.gov registry record · NA

The Utility of Cap Colonoscopy in Increasing Adenoma Detection Rate

A NA study, sponsored by Texas Tech University Health Sciences Center, El Paso.

Terminated
Registry status
NA
Development phase
440
Enrollment target

NCT01601431: Clinical Trial NA study, sponsored by Texas Tech University Health Sciences Center, El Paso.

NCT01601431 is a NA study that was terminated before completion, run by Texas Tech University Health Sciences Center, El Paso. The registered enrollment target is 440 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01601431, a NA study, was terminated before completion, sponsored by Texas Tech University Health Sciences Center, El Paso.

TERMINATED
Registry status
NA
Development phase
440 participants
Enrollment target

Study Summary

This is a research study about the usefulness of transparent cap during screening colonoscopy. The purpose of the research is to test the usefulness of adding small cap to the tip of the colonoscope. the investigators hypothesis is that Cap assisted colonoscopy will improve the detection of adenomatous polyps (polyps which can become colon cancer later on) in comparison to the standard colonoscopy.

Primary Outcome

1\. Compare ADR between Hispanic patients undergoing a screening colonoscopy with and without cap.

Interventions

  • DEVICE Cap Assisted Colonoscopy
  • DEVICE Conventional colonoscopy

Trial Details

FieldValue
Enrollment Target 440 participants
Start Date 2012-03-29
Est. Completion 2015-02-02
Phase NA

Why NCT01601431 stopped before completion

NCT01601431 is an interventional study that assigns participants to a tested intervention. The registered 440 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).

The record links to 0 conditions, and to 2 interventions - of which Cap Assisted Colonoscopy is the first listed.

NCT01601431 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01601431 about?

NCT01601431 is a clinical study titled "The Utility of Cap Colonoscopy in Increasing Adenoma Detection Rate". This is a research study about the usefulness of transparent cap during screening colonoscopy. The purpose of the research is to test the usefulness of adding small cap to the tip of the colonoscope. the investigators hypothesis is that Cap assisted colonoscopy will improve the detection of adenomat...

What is the current status of trial NCT01601431?

This trial is currently terminated. It is a NA study. The enrollment target is 440 participants. The study started on 2012-03-29. Estimated completion is 2015-02-02.

What interventions are being tested in trial NCT01601431?

The interventions under investigation include: Cap Assisted Colonoscopy (DEVICE), Conventional colonoscopy (DEVICE).

Who is sponsoring clinical trial NCT01601431?

This trial is sponsored by Texas Tech University Health Sciences Center, El Paso, which has 35 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01601431's enrollment target sits among peer trials

440 233rd of 2000 higher than 1,766 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05114538 · 440 participants · NA

    Improving the Part C Early Intervention Service Delivery System for Children with ASD

  • NCT05117619 · 440 participants · NA

    The HOME Program for Individuals With Traumatic Brain Injury and Family Members

  • NCT05602194 · 440 participants · Phase 3

    Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma

  • NCT05624879 · 440 participants · NA

    Accelerated Resolution Therapy for Early Maladaptive Grief

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01601431, the US trial registry maintained by the National Library of Medicine. NCT01601431 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.